This once-weekly injection for chronic weight management may be the answer for adults who are overweight or obese and have at least one weight-related health condition. Designed with remarkable results in mind. On average, our patients shed 22 pounds in just 12 weeks.
What is Semaglutide/GLP-1?
Semaglutide/GLP-1 is the first approved drug for chronic weight management in obese or overweight adults as a weight loss program. Approximately 70% of American adults are obese or overweight, a severe health issue associated with heart disease, stroke, and diabetes, linked to an increased risk of certain types of cancer. Losing 5% to 10% of body weight through diet and exercise reduces the risk of cardiovascular disease, but diet and exercise alone are not always guaranteed to address the issue.